首页> 外文期刊>Pathology International >Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases
【24h】

Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases

机译:增强PD-L1表达在初级皮肤大T细胞淋巴瘤中肿瘤细胞的表达,CD30表达为经典霍奇金淋巴瘤模拟:两种情况下的淋巴结病变报告

获取原文
获取原文并翻译 | 示例
           

摘要

Neoplastic PD-L1 (nPD-L1, clone SP142) expression remains unclear in cutaneous T-cell lymphoma (CTCL), although it is well-documented in classic Hodgkin lymphoma (CHL). Here, we report two cases of primary cutaneous large T-cell lymphoma (PCLTCL) with CD30 expression that developed secondary nodal lesions morphologically mimicking CHL, and describe their PD-L1 expression. Our two cases (52- and 60-year-old males) had long-standing clinical courses of CTCL. Their PCLTCL with CD30 expression developed nodal lesions, having a nodular growth pattern containing scattered CD30+ Hodgkin and Reed-Sternberg-like and/or lacunar cells that expressed CD15 but did not harbor Epstein-Barr virus. Their differential diagnosis from CHL was challenging. A diagnosis of PCLTCL with secondary nodal involvement featuring CHL mimicry was based on comparison of the primary and secondary lesions. In one case, shared expression of the same T-cell antigen was revealed by immunohistochemistry, and in the other, identical clonalTCRrearrangement was demonstrated by polymerase chain reaction (PCR). Interestingly, nPD-L1 was expressed on more than 50% of the tumor cells in the secondary nodal lesions, but on very few in the primary cutaneous lesions, in both cases. This is the first report of nPD-L1 expression greatly increasing with PCLTCL tumor progression to nodal involvement.
机译:肿瘤性PD-L1(nPD-L1,克隆SP142)在皮肤T细胞淋巴瘤(CTCL)中的表达尚不清楚,尽管在经典霍奇金淋巴瘤(CHL)中已有大量文献报道。在这里,我们报告了两例CD30表达的原发性皮肤大T细胞淋巴瘤(PCLTCL),在形态学上形成了类似CHL的继发性淋巴结病变,并描述了它们的PD-L1表达。我们的两个病例(52岁和60岁男性)有长期的CTCL临床病程。他们表达CD30的PCLTCL出现结节性病变,结节性生长模式包括分散的CD30+霍奇金和里德-斯特恩伯格样细胞和/或腔隙性细胞,这些细胞表达CD15,但不携带爱泼斯坦-巴尔病毒。他们与CHL的鉴别诊断具有挑战性。根据原发性和继发性病变的比较,诊断为以CHL拟态为特征的继发性淋巴结受累的PCLTCL。在一个病例中,免疫组织化学显示相同T细胞抗原的共同表达,而在另一个病例中,聚合酶链反应(PCR)显示相同的克隆重组。有趣的是,nPD-L1在继发性淋巴结病变中50%以上的肿瘤细胞上表达,但在两种情况下,在原发性皮肤病变中很少表达。这是首次报道nPD-L1表达随着PCLTCL肿瘤进展到淋巴结受累而显著增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号